John Aunins Net Worth & Insider Trades
John Aunins - Chief Technology Officer & EVP, Seres Therapeutics, Inc
What is John Aunins's Net Worth?
The current estimated net worth of Seres Therapeutics, Inc's Chief Technology Officer & EVP, John Aunins, is estimated to be about $3.81M . John Aunins owns about 85,250 units of Seres Therapeutics, Inc common stock. In the last 3 years at Seres Therapeutics, Inc, John Aunins has sold an estimated value of $3.25M worth.
What is John Aunins's Past Insider Trading?
John Aunins's largest purchase order was 187,500 units , worth over $90K on July 26, 2016. John Aunins's largest sale order was 18,640 units , worth over $595.36K on April 27, 2016. In total, John Aunins has made about 22 transactions over 3 years of their time at Seres Therapeutics, Inc. John Aunins usually trades in June, with the busiest year in 2018 and 2016. The most recent transaction was a sale order of 14,282 units , worth over $91.31K on December 19, 2018.
John G Aunins
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What is John Aunins's' Mailing Address?
- Mailing address is C/o Seres Health, Inc. 161 First Street Cambridge MA 02472 MA
Seres Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|
Eric D. Shaff | 2020 | $590,000 | - | $2,050,600 | $486,750 | $8,550 | $3,135,900 |
Eric D. Shaff | 2019 | $540,000 | - | $1,231,148 | $253,000 | $8,400 | $2,032,548 |
Thomas J. DesRosier | 2020 | $450,000 | - | $717,710 | $261,000 | $8,550 | $1,437,260 |
Thomas J. DesRosier | 2019 | $428,300 | - | $379,641 | $161,000 | $8,400 | $977,341 |
David S. Ege, Ph.D. | 2020 | $76,923 | $65,000 | $5,175,880 | - | $785 | $5,318,587 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1609809/000119312521144988/d77986ddef14a.htm
What are Seres Therapeutics, Inc's Past Insider Trades?
Seres Therapeutics, Inc's most recent insider trade came on October 31, 2022 by David S Ege who sold 5,012 units worth $39.75K . In the last 6 years, insiders at Seres Therapeutics, Inc have sold an estimated value of $57.98M and bought an estimated value of $75.14M worth of shares. Insider trading is most common in June, with the busiest year in 2016. The most active traders at the company are Roger Pomerantz, Director, John G Aunins, Chief Technology Officer & EVP, and Eric D Shaff, CEO and President .
Seres Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |